UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029305
Receipt number R000033343
Scientific Title A study for the short-term application of topical product CG_01.
Date of disclosure of the study information 2017/09/27
Last modified on 2019/10/01 10:08:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study for the short-term application of topical product CG_01.

Acronym

A study for the short-term application of topical product CG_01.

Scientific Title

A study for the short-term application of topical product CG_01.

Scientific Title:Acronym

A study for the short-term application of topical product CG_01.

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Dermatology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effect of the topical agent on components of the skin and its relevance to skin conditions.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The dryness score of the skin before and after application.

Key secondary outcomes

The skin hydration, pH, the image analysis of the skin surface, the analysis of components of the skin, the analysis of the questionnaire before and after application.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Apply the active agent to the one side of the cheek and the placebo to other side of the cheek twice a day for 8 days.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

25 years-old <=

Age-upper limit

50 years-old >=

Gender

Male

Key inclusion criteria

1. Healthy males aged from 25 to 50 years old.
2. Subjects with a high dryness score and a low skin hydration of the cheek selected by screening test.
3. Subjects who can agree to participate in the study and provide written informed consent.

Key exclusion criteria

1. Subjects with atopic dermatitis, contact dermatitis and cutaneous hypersensitivity
2. Subjects with problems in the skin of the face, such as wound, eczema, sunburn.
3. Subjects who is using topical agent on the skin of the face.
4. Subjects who attend a hospital or who take drugs.
5. Subjects with any allergies.
6. Subjects who is undergoing, or have received, medical cosmetic treatment such as chemical peeling, cosmetic surgery.
7. Smoker.
8. Subjects who is participating in, or have participated in, other clinical study.
9. Subjects deemed inappropriate to participate in this study by the principle investigator.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shinobu Mori

Organization

Kao Corporation

Division name

Biological Science Research

Zip code


Address

2606, Akabane, Ichikai-machi, haga-gun, Tochigi, 321-3497, JAPAN

TEL

+81-285-68-7460

Email

mori.shinobu@kao.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Satoko Fukagawa

Organization

Kao Corporation

Division name

Biological Science Research

Zip code


Address

2606, Akabane, Ichikai-machi, haga-gun, Tochigi, 321-3497, JAPAN

TEL

+81-285-68-7579

Homepage URL


Email

fukagawa.satoko@kao.co.jp


Sponsor or person

Institute

Kao Corporation

Institute

Department

Personal name



Funding Source

Organization

Kao Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

花王株式会社(栃木県)


Other administrative information

Date of disclosure of the study information

2017 Year 09 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 09 Month 20 Day

Date of IRB

2017 Year 09 Month 20 Day

Anticipated trial start date

2017 Year 09 Month 27 Day

Last follow-up date

2017 Year 12 Month 25 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 09 Month 27 Day

Last modified on

2019 Year 10 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033343


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name